Carcinoma in situ of liver, gallbladder and bile ducts

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries Inpat., Oupat., Death

Hospital Discharge: ICD-10 D01.5&
Hospital discharge: ICD-9 2308
Cause of death: ICD-10 D01.5&
Cause of death: ICD-9 2308

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector CD2_INSITU_LIVER_GALLBLADDER_BILE

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D01
Name in latin Carcinoma in situ hepatis

Similar endpoints

List of similar endpoints to Carcinoma in situ of liver, gallbladder and bile ducts based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

None

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals - - -
Unadjusted prevalence (%) - - -
Mean age at first event (years) - - -

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Correlations

Index endpoint: CD2_INSITU_LIVER_GALLBLADDER_BILE – Carcinoma in situ of liver, gallbladder and bile ducts
GWS hits:

Survival analyses between endpoints

Plot

before Carcinoma in situ of liver, gallbladder and bile ducts
after Carcinoma in situ of liver, gallbladder and bile ducts

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Carcinoma in situ of liver, gallbladder and bile ducts